Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Thermo Fisher Scientific

US

Last updated May 23, 2026

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (81)

Page 1 of 2
DeviceModel / ReferenceRegistriesClassStatus
Cascadion™ SM 25-Hydroxy Vitamin D Control 3 NONE
FDA UDI
Class IIUnknown
Storage 1
FDA UDI
Class IActive
Cascadion™ SM 25-Hydroxy Vitamin D Calibrator Set NONE
FDA UDI
Class IIUnknown
Recapper, 110V, TCA 1
FDA UDI
Class IActive
Indiko Plus 864
FDA UDI
Class IActive
Cascadion™ SM 25-Hydroxy Vitamin D Control 2 NONE
FDA UDI
Class IIActive
Cascadion™ SM 25-Hydroxy Vitamin D Control 1 NONE
FDA UDI
Class IIActive
Cascadion™ SM 25-Hydroxy Vitamin D Internal Standard NONE
FDA UDI
Class IIActive
Indiko 863
FDA UDI
Class IActive
Interface, TCA ImmunoCap 1000 1
FDA UDI
Class IActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL K252062
FDA 510(k)
Class IIActive
Sensititre Susceptibility Plates K143381
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL K243169
FDA 510(k)
Class IIActive
Sensititre 18-24 hours MIC or BP Susceptibility System with Ceftolozane/tazobactam (0.03/4- 64/4ug/mL) K150556
FDA 510(k)
Class IIActive
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL K231433
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Imipenem-Relebactam in the dilution range of 0.03/4-256/4 ug/mL K192250
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 ug/ml K203741
FDA 510(k)
Class IIActive
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL K243738
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.0005 – 8 ug/mL K171870
FDA 510(k)
Class IIActive
Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Dalbavancin (0.0005 - 2ug/mL) K150236
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Eravacycline in the dilution range of 0.008- 16 µg/mL K182797
FDA 510(k)
Class IIActive
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Imipenem in the dilution range of 0.015 - 4 ug/ml. K240445
FDA 510(k)
Class IIActive
Sensititre Haemophilus / Streptococcus Pneumoniae (hp) Susceptibility Plates K133847
FDA 510(k)
Class IIActive
Thermo Scientific Sensititre ARIS HiQ System K191914
FDA 510(k)
Class IIActive
Immunocap Allergen K82 K121463
FDA 510(k)
Class IIActive
Sensititre 18-24 Hour Mic Suceptibility System K133773
FDA 510(k)
Class IIActive
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with ceftriaxone in the dilution range of 0.015 - 2 ug/ml. K241967
FDA 510(k)
Class IIActive
Sensititre Susceptibility Plates K141651
FDA 510(k)
Class IIActive
The Sensititre HP MIC Susceptibility plate with Oritavancin (0.0005-8mcg/ml) K143526
FDA 510(k)
Class IIActive
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.00025-8ug/ml (Streptococcus species) and 0.000125-8ug/ml (Haemophilus influenzae) K223844
FDA 510(k)
Class IIActive
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Meropenem in the dilution range of 0.015 - 32 ug/ml. K242021
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Sulbactam-durlobactam in the dilution range of 0.015/4-32/4 ug/mL K231994
FDA 510(k)
Class IIActive
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dalbavancin in the dilution range of 0.0005-2µg/ml K231988
FDA 510(k)
Class IIActive
Dri Methadone Metabolite (100/300) Assay, Calibrators And Controls K081378
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL K242658
FDA 510(k)
Class IIActive
Qms Lidocaine K090282
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL K242659
FDA 510(k)
Class IIActive
Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mL K181946
FDA 510(k)
Class IIActive
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml K221899
FDA 510(k)
Class IIActive
Sensititre 20-24 hour Haemophilus influenzaelStreptococcus pneumoniae MIC or Breakpoint Susceptibility System with Ceftolozane-tazobactam in the dilution range of 0.03/4-64/4ug/ml K232310
FDA 510(k)
Class IIActive
Mas Tox Control K080085
FDA 510(k)
Class IActive
Carbon Dioxide (co2), Scal, Nortrol And Abtrol K071340
FDA 510(k)
Class IIActive
Amylase Eps Reagent K070064
FDA 510(k)
Class IIActive
Spectra Mrsa K073027
FDA 510(k)
Class IIActive
Sensititre Haemophilus/Streptococcus Pneumoniae(hp) Susceptibility Plates K140985
FDA 510(k)
Class IIActive
Sensititre 18-24 Hour Susceptibility Plates K142151
FDA 510(k)
Class IIActive
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mL K242657
FDA 510(k)
Class IIActive
Ise Module And Bar Code Reader Addition For The Datapro Clinical Chemistry Analyzer K070531
FDA 510(k)
Class IIActive
Remel Spectra Vre K092819
FDA 510(k)
Class IIActive
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of 0.015-32 ug/mL K243201
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (5)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Sep 23, 2010Z-1735-2011—terminated

Through internal quality review, firm determined the need to conduct a more comprehensive system validation to support the claim of complete bacterial, fungal and viral disinfection efficacy.

Sep 23, 2010Z-1734-2011—terminated

Through internal quality review, firm determined the need to conduct a more comprehensive system validation to support the claim of complete bacterial, fungal and viral disinfection efficacy.

Jun 3, 2009Z-1320-2010—terminated

The firm has received complaints regarding specimen integrity (higher rate of specimen fragmentation) as well as complaints that the chamber may stop rotating prematurely, resulting in sample deterioration.

May 1, 2008Z-2159-2008—terminated

Assay tests on retention sample of 10% Buffered Formalin Phosphate showed it to be 3.417%, which is below the specification of 4-5%.

Jul 24, 2007Z-0015-2008—terminated

Method is susceptible to positive interference from endogenous ALT in patient samples.